Form 144/A - Report of proposed sale of securities: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 144/A - Report of proposed sale of securities: [Amend]

Evolent Health (NYSE:EVH)
Historical Stock Chart
From Sep 2024 to Oct 2024

Click Here for more Evolent Health Charts.

Evolent Health (NYSE:EVH)
Historical Stock Chart
From Oct 2023 to Oct 2024

Click Here for more Evolent Health Charts.

Evolent Health Inc News

Evolent To Release Third Quarter 2024 Financial Results on Thursday, November 7, 2024
Friday 11 October 2024 (1 week ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 26 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Friday 23 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 22 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 22 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 22 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 22 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 8 August 2024 (2 months ago) • Edgar (US Regulatory)

More Evolent Health Inc News Articles

Virexit Technologies (PK)

Digital Brand Media and ... (PK)

Elite Pharmaceuticals (QB)

Fannie Mae (QB)

Anavex Life Sciences

GNCC Capital (CE)

Lightwave Logic

Rennova Health (CE)

Intergrated Cannabis Sol... (PK)

Northwest Biotherapeutics (QB)

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions